Geneos Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-242
| Closed | -$736 | – | 3183 |
|
|
2024
Q4 | $736 | Hold |
242
| – | – | ﹤0.01% | 2832 |
|
|
2024
Q3 | $1.26K | Buy |
+242
| New | +$1.26K | ﹤0.01% | 2396 |
|
|
2021
Q4 | – | Sell |
-5,840
| Closed | -$162K | – | 2895 |
|
|
2021
Q3 | $162K | Hold |
5,840
| – | – | 0.01% | 952 |
|
|
2021
Q2 | $177K | Sell |
5,840
-200
| -3% | -$6.06K | 0.01% | 903 |
|
|
2021
Q1 | $175K | Hold |
6,040
| – | – | ﹤0.01% | 1031 |
|
|
2020
Q4 | $163K | Buy |
+6,040
| New | +$163K | 0.01% | 914 |
|